Prognostic value of a TDCP (Total bilirubin–Direct bilirubin–Creatinine–Platelet) index in locally advanced rectal cancer after neoadjuvant therapy: Multicenter study in patients with normal CEA/CA19-9
Prognostic value of a TDCP (Total bilirubin–Direct bilirubin–Creatinine–Platelet) index in locally advanced rectal cancer after neoadjuvant therapy: Multicenter study in patients with normal CEA/CA19-9. // Surgical Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0960740426001763?dgcid=rss_sd_all
Prognostic value of a TDCP (Total bilirubin–Direct bilirubin–Creatinine–Platelet) index in locally advanced rectal cancer after neoadjuvant therapy: Multicenter study in patients with normal CEA/CA19-9. Surgical Oncology. https://www.sciencedirect.com/science/article/pii/S0960740426001763?dgcid=rss_sd_all
“Prognostic value of a TDCP (Total bilirubin–Direct bilirubin–Creatinine–Platelet) index in locally advanced rectal cancer after neoadjuvant therapy: Multicenter study in patients with normal CEA/CA19-9.” Surgical Oncology.
@article{article66973,
title = {Prognostic value of a TDCP (Total bilirubin–Direct bilirubin–Creatinine–Platelet) index in locally advanced rectal cancer after neoadjuvant therapy: Multicenter study in patients with normal CEA/CA19-9},
journal = {Surgical Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0960740426001763?dgcid=rss_sd_all}
}